胃解剖改变患者小肠胶囊内镜可行性与诊断率:SAGA研究
该多中心回顾性研究纳入243例胃手术后患者共248次小肠胶囊内镜(SB-CE),主要指征为不明原因消化道出血(85.1%)。
要点
- 胃手术后患者口服小肠胶囊内镜完成率84.3%,诊断率43.6%。
- 最常见指征为不明原因消化道出血(85.1%)。
核心结论
- 在有重大胃手术史的选择性患者中,小肠胶囊内镜似乎可行且安全,并具有较高的诊断率。
- 此类患者的小肠异常发现谱可能不同于未手术患者已知的文献报道。
研究设计与样本
- 24家欧洲中心回顾性识别胃全切或次全切后接受小肠胶囊内镜的患者。
- 共分析243例患者的248次检查,平均年龄62岁。
主要发现
- 小肠完成率为84.3%,小肠传输时间中位数286分钟(四分位距235–387)。
- 排除上部吻合口部位异常后,诊断率为43.6%,炎症/溃疡性病变(23.4%)多于血管性病变(21.0%)。
关键数值与推荐
- 诊断率定义为中高度相关(P1至P2)发现,排除上部吻合口部位异常后为43.6%。
- 胃手术类型构成:部分胃切除(Billroth I 13.1%、Billroth II 34.6%)、全胃切除7.4%、Whipple手术12.8%、袖状胃切除7.2%、胃旁路手术24.7%。
临床怎么用
- 对选择性胃手术后不明原因消化道出血患者,可考虑口服小肠胶囊内镜评估小肠。
- 需注意此类患者小肠病变谱可能与非手术患者不同,判读时应结合胃手术史。
局限性
- 回顾性设计,仅纳入选择性患者,结果外推需谨慎。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Little is known about small-bowel (SB) capsule endoscopy (CE) in patients with a history of gastric surgery. This study aims to evaluate the feasibility and diagnostic yield (DY) of orally ingested SB-CE in patients with surgically altered gastric anatomy. METHODS: Twenty-four European centers retrospectively identified patients who had SB-CE after total or subtotal gastrectomy. The primary outcome was the DY of SB-CE (intermediate P1 to highly P2 relevant findings). Secondary outcomes were gastric and SB transit times, completion, cleanliness, and adverse event rates. RESULTS: Studied were 248 procedures from 243 patients (mean age, 62 years) with a history of partial gastrectomy (Billroth I, 13.1%; Billroth II, 34.6%), total gastrectomy (7.4%), Whipple procedure (12.8%), sleeve gastrectomy (7.2%), or gastric bypass surgery (24.7%). Obscure GI bleeding was the most frequent indication (85.1%). SB completion rate was 84.3%. One capsule retention in the SB was noted (adverse event rate, .4%). Median SB transit time was 286 minutes (interquartile range [235; 387]). Cleanliness was rated as adequate in 92.1% of procedures. After exclusion of abnormalities found at the upper anastomotic site, the DY was 43.6%, with inflammatory/ulcerated lesions observed more frequently (23.4%) than vascular lesions (21.0%). CONCLUSIONS: SB-CE seems to be feasible and safe in selected patients with a history of major gastric surgery and comes with a high DY. The spectrum of abnormal SB findings in these patients may be different from what is known from the literature in nonoperated patients.
引用
- Dray X, Riccioni ME, Wurm Johansson G, et al. Feasibility and diagnostic yield of small-bowel capsule endoscopy in patients with surgically altered gastric anatomy: the SAGA study. Gastrointest Endosc. 2021. PMID: 33848508. doi:10.1016/j.gie.2021.03.934
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。